CD99瘤相关抗原是T细胞急性淋巴细胞白血病抗体治疗的潜在目标
Kamonporn Kotemul1, Watchara Kasinrerk1,2, Nuchjira Takheaw1,2
1Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
Exploration of targeted anti-tumor therapy
|March 12, 2024
概括
针对CD99抗原的单克隆抗体显示出治疗T细胞急性淋巴细胞白血病 (T-ALL) 的前景. 这些抗体选择性地杀死T-ALL细胞,提供了潜在的新疗法,副作用较少.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 单克隆抗体 (mAbs) 在向癌症免疫治疗中有效.
- 由于缺乏特定的点,T细胞急性淋巴细胞白血病 (T-ALL) 仍然是抗体治疗的挑战.
- 常规化疗往往导致T-ALL患者的复发和耐药性.
研究的目的:
- 审查CD99作为T细胞急性淋巴细胞白血病 (T-ALL) 的治疗点的潜力.
- 评估抗CD99单克隆抗体 (mAbs) 在T-ALL治疗中的有效性和安全性.
- 巩固过去25年来对抗CD99mAbs的研究.
主要方法:
- 关于抗CD99单克隆抗体及其对T-ALL的影响的科学文献的综述.
- 对恶性T细胞与非恶性T细胞的CD99表达水平的分析.
- 对研究对抗CD99mAbs对T-ALL细胞亡的直接作用的研究进行了审查.
主要成果:
- CD99在恶性T细胞上表达高,在非恶性T细胞上表达低,使其成为合适的点.
- 某些抗CD99mAbs的克隆已经证明能够在恶性T细胞中特别诱导亡.
- 超过25年的研究表明,对抗CD99mAbs对T-ALL的直接影响进行了重要的研究.
结论:
- 抗CD99mAbs是T细胞急性淋巴细胞白血病 (T-ALL) 的一个有前途的治疗策略.
- 向CD99提供了通过节省非恶性T细胞的高效率和减少不良影响的潜力.
- 对抗CD99mAbs的进一步开发可能会导致一种新的基于抗体的T-ALL治疗.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.7K
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K